The Antiviral Effect of Nirmatrelvir/Ritonavir during COVID-19 Pandemic Real-World Data

Introduction: Vaccination against SARS-CoV-2 and the prevalence of Omicron variants have reduced the risk of the severe clinical progress of COVID-19. However, the risk of breakthrough infections has increased, and early administration of an effective antiviral treatment is significant in order to p...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrakis, Vasilios, Rafailidis, Petros, Trypsianis, Grigorios, Papazoglou, Dimitrios, Panagopoulos, Periklis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144059/
https://www.ncbi.nlm.nih.gov/pubmed/37112956
http://dx.doi.org/10.3390/v15040976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144059/
https://www.ncbi.nlm.nih.gov/pubmed/37112956
http://dx.doi.org/10.3390/v15040976

Ejemplares similares